25 XP   0   0   10

Jointown Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Jointown Pharmaceutical Group Co Ltd together

PenkeI guess you are interested in Jointown Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jointown Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jointown Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Jointown Pharmaceutical Group Co Ltd.

Quick analysis of Jointown Pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Jointown Pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥7.89
Expected worth in 1 year
¥8.32
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥0.86
Return On Investment
10.1%

For what price can you sell your share?

Current Price per Share
¥8.51
Expected price per share
¥7.8071 - ¥8.95
How sure are you?
50%

1. Valuation of Jointown Pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.51

Intrinsic Value Per Share

¥-8.38 - ¥-10.37

Total Value Per Share

¥-0.48 - ¥-2.48

2. Growth of Jointown Pharmaceutical Group Co Ltd (5 min.)




Is Jointown Pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$4.2b$3.9b$138.3m3.4%

How much money is Jointown Pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$74.3m$75.8m-$1.4m-2.0%
Net Profit Margin1.4%1.5%--

How much money comes from the company's main activities?

3. Financial Health of Jointown Pharmaceutical Group Co Ltd (5 min.)




4. Comparing to competitors in the Pharmaceutical Retailers industry (5 min.)




  Industry Rankings (Pharmaceutical Retailers)  

What can you expect buying and holding a share of Jointown Pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! Jointown Pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Jointown Pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of Jointown Pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of Jointown Pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jointown Pharmaceutical Group Co Ltd is ¥8.51. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jointown Pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jointown Pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.89. Based on the TTM, the Book Value Change Per Share is ¥0.11 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jointown Pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.2%0.020.2%0.020.2%0.020.2%0.010.2%
Usd Book Value Change Per Share0.050.6%0.010.2%0.010.2%0.020.2%0.020.2%
Usd Dividend Per Share0.010.1%0.020.2%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.060.7%0.030.3%0.030.3%0.030.4%0.030.4%
Usd Price Per Share1.11-1.04-1.27-1.39-1.62-
Price to Earnings Ratio14.65-14.80-18.01-29.80-49.69-
Price-to-Total Gains Ratio19.33-3.67-49.47-51.17-56.18-
Price to Book Ratio1.02-1.00-1.26-1.54-2.98-
Price-to-Total Gains Ratio19.33-3.67-49.47-51.17-56.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.176933
Number of shares849
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.010.02
Usd Total Gains Per Share0.030.03
Gains per Quarter (849 shares)25.2026.35
Gains per Year (849 shares)100.81105.40
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1515091396695
210210019279132200
3153149293118198305
4204199394157265410
5255249495196331515
6306299596236397620
7357349697275463725
8408399798314529830
9459448899353595935
1051049810003936611040

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%53.00.00.0100.0%
Book Value Change Per Share2.02.00.050.0%9.03.00.075.0%15.05.00.075.0%32.08.00.080.0%44.09.00.083.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%53.00.00.0100.0%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%18.02.00.090.0%36.04.00.090.0%49.04.00.092.5%

Fundamentals of Jointown Pharmaceutical Group Co Ltd

About Jointown Pharmaceutical Group Co Ltd

Jointown Pharmaceutical Group Co., Ltd provides pharmaceutical supply chain services in China. It is also involved in general agency brand promotion; digital retail; intelligent logistics and supply chain solutions; and medical health and technology value-added service businesses. In addition, the company manufactures western medicines, such as antibiotics, anti-diabetic drugs, and cardiovascular drugs; and other OEM medicines. The company was founded in 1999 and is based in Wuhan, China.

Fundamental data was last updated by Penke on 2024-05-12 23:13:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Jointown Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jointown Pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jointown Pharmaceutical Group Co Ltd to the Pharmaceutical Retailers industry mean.
  • A Net Profit Margin of 1.3% means that ¥0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jointown Pharmaceutical Group Co Ltd:

  • The MRQ is 1.3%. The company is making a profit. +1
  • The TTM is 1.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.3%TTM1.4%-0.1%
TTM1.4%YOY1.5%-0.1%
TTM1.4%5Y1.9%-0.4%
5Y1.9%10Y1.7%+0.2%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%0.4%+0.9%
TTM1.4%0.4%+1.0%
YOY1.5%0.3%+1.2%
5Y1.9%1.1%+0.8%
10Y1.7%1.4%+0.3%
1.1.2. Return on Assets

Shows how efficient Jointown Pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jointown Pharmaceutical Group Co Ltd to the Pharmaceutical Retailers industry mean.
  • 0.6% Return on Assets means that Jointown Pharmaceutical Group Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jointown Pharmaceutical Group Co Ltd:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.6%0.0%
TTM0.6%YOY0.6%0.0%
TTM0.6%5Y0.7%-0.1%
5Y0.7%10Y0.7%+0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%0.3%+0.3%
TTM0.6%0.3%+0.3%
YOY0.6%0.3%+0.3%
5Y0.7%0.3%+0.4%
10Y0.7%0.2%+0.5%
1.1.3. Return on Equity

Shows how efficient Jointown Pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jointown Pharmaceutical Group Co Ltd to the Pharmaceutical Retailers industry mean.
  • 2.2% Return on Equity means Jointown Pharmaceutical Group Co Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jointown Pharmaceutical Group Co Ltd:

  • The MRQ is 2.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.2%TTM2.2%0.0%
TTM2.2%YOY2.3%-0.1%
TTM2.2%5Y2.7%-0.5%
5Y2.7%10Y2.3%+0.3%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2%0.9%+1.3%
TTM2.2%1.0%+1.2%
YOY2.3%1.3%+1.0%
5Y2.7%0.8%+1.9%
10Y2.3%0.8%+1.5%

1.2. Operating Efficiency of Jointown Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jointown Pharmaceutical Group Co Ltd is operating .

  • Measures how much profit Jointown Pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jointown Pharmaceutical Group Co Ltd to the Pharmaceutical Retailers industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jointown Pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.0%-1.0%
TTM1.0%YOY3.0%-2.1%
TTM1.0%5Y2.7%-1.8%
5Y2.7%10Y1.7%+1.1%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.2%+4.2%
TTM1.0%0.5%+0.5%
YOY3.0%0.8%+2.2%
5Y2.7%0.9%+1.8%
10Y1.7%0.5%+1.2%
1.2.2. Operating Ratio

Measures how efficient Jointown Pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • An Operation Ratio of 1.90 means that the operating costs are ¥1.90 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jointown Pharmaceutical Group Co Ltd:

  • The MRQ is 1.901. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.890. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.901TTM1.890+0.010
TTM1.890YOY1.892-0.002
TTM1.8905Y1.885+0.006
5Y1.88510Y1.498+0.387
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9011.682+0.219
TTM1.8901.672+0.218
YOY1.8921.556+0.336
5Y1.8851.541+0.344
10Y1.4981.391+0.107

1.3. Liquidity of Jointown Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jointown Pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A Current Ratio of 1.26 means the company has ¥1.26 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jointown Pharmaceutical Group Co Ltd:

  • The MRQ is 1.257. The company is just able to pay all its short-term debts.
  • The TTM is 1.256. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.257TTM1.256+0.001
TTM1.256YOY1.269-0.013
TTM1.2565Y1.269-0.013
5Y1.26910Y0.766+0.503
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2571.258-0.001
TTM1.2561.219+0.037
YOY1.2691.157+0.112
5Y1.2691.439-0.170
10Y0.7661.246-0.480
1.3.2. Quick Ratio

Measures if Jointown Pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jointown Pharmaceutical Group Co Ltd to the Pharmaceutical Retailers industry mean.
  • A Quick Ratio of 0.59 means the company can pay off ¥0.59 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jointown Pharmaceutical Group Co Ltd:

  • The MRQ is 0.586. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.558. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.586TTM0.558+0.029
TTM0.558YOY0.677-0.120
TTM0.5585Y0.643-0.085
5Y0.64310Y0.661-0.017
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5860.432+0.154
TTM0.5580.504+0.054
YOY0.6770.507+0.170
5Y0.6430.577+0.066
10Y0.6610.690-0.029

1.4. Solvency of Jointown Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jointown Pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jointown Pharmaceutical Group Co Ltd to Pharmaceutical Retailers industry mean.
  • A Debt to Asset Ratio of 0.68 means that Jointown Pharmaceutical Group Co Ltd assets are financed with 68.3% credit (debt) and the remaining percentage (100% - 68.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jointown Pharmaceutical Group Co Ltd:

  • The MRQ is 0.683. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.688. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.683TTM0.688-0.005
TTM0.688YOY0.694-0.007
TTM0.6885Y0.689-0.002
5Y0.68910Y0.684+0.005
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6830.641+0.042
TTM0.6880.646+0.042
YOY0.6940.661+0.033
5Y0.6890.645+0.044
10Y0.6840.601+0.083
1.4.2. Debt to Equity Ratio

Measures if Jointown Pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jointown Pharmaceutical Group Co Ltd to the Pharmaceutical Retailers industry mean.
  • A Debt to Equity ratio of 270.3% means that company has ¥2.70 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jointown Pharmaceutical Group Co Ltd:

  • The MRQ is 2.703. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.667. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.703TTM2.667+0.036
TTM2.667YOY2.642+0.025
TTM2.6675Y2.605+0.062
5Y2.60510Y2.438+0.168
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7031.616+1.087
TTM2.6671.531+1.136
YOY2.6422.011+0.631
5Y2.6051.975+0.630
10Y2.4381.602+0.836

2. Market Valuation of Jointown Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jointown Pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Jointown Pharmaceutical Group Co Ltd to the Pharmaceutical Retailers industry mean.
  • A PE ratio of 14.65 means the investor is paying ¥14.65 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jointown Pharmaceutical Group Co Ltd:

  • The EOD is 15.467. Based on the earnings, the company is fair priced.
  • The MRQ is 14.649. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.799. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD15.467MRQ14.649+0.818
MRQ14.649TTM14.799-0.150
TTM14.799YOY18.013-3.214
TTM14.7995Y29.799-15.000
5Y29.79910Y49.686-19.887
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD15.46710.481+4.986
MRQ14.6499.510+5.139
TTM14.79910.290+4.509
YOY18.0135.593+12.420
5Y29.7994.915+24.884
10Y49.68614.185+35.501
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jointown Pharmaceutical Group Co Ltd:

  • The EOD is -2.149. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.035. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 27.598. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-2.149MRQ-2.035-0.114
MRQ-2.035TTM27.598-29.633
TTM27.598YOY14.303+13.295
TTM27.5985Y15.167+12.431
5Y15.16710Y7.115+8.052
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-2.1491.496-3.645
MRQ-2.0351.125-3.160
TTM27.5980.939+26.659
YOY14.3030.506+13.797
5Y15.1671.591+13.576
10Y7.115-0.577+7.692
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jointown Pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A PB ratio of 1.02 means the investor is paying ¥1.02 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Jointown Pharmaceutical Group Co Ltd:

  • The EOD is 1.078. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.021. Based on the equity, the company is underpriced. +1
  • The TTM is 1.004. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.078MRQ1.021+0.057
MRQ1.021TTM1.004+0.017
TTM1.004YOY1.258-0.255
TTM1.0045Y1.540-0.536
5Y1.54010Y2.984-1.444
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD1.0781.423-0.345
MRQ1.0211.196-0.175
TTM1.0041.378-0.374
YOY1.2581.468-0.210
5Y1.5401.851-0.311
10Y2.9842.786+0.198
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jointown Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3540.106+233%0.105+237%0.141+151%0.149+137%
Book Value Per Share--7.8957.531+5%7.275+9%6.707+18%5.071+56%
Current Ratio--1.2571.256+0%1.269-1%1.269-1%0.766+64%
Debt To Asset Ratio--0.6830.688-1%0.694-2%0.689-1%0.6840%
Debt To Equity Ratio--2.7032.667+1%2.642+2%2.605+4%2.438+11%
Dividend Per Share--0.0630.109-42%0.083-24%0.084-25%0.085-25%
Eps--0.1380.138+0%0.140-2%0.150-8%0.108+28%
Free Cash Flow Per Share---0.9900.202-591%0.153-746%0.151-758%0.109-1010%
Free Cash Flow To Equity Per Share---0.9900.058-1798%-0.051-95%0.005-18569%0.011-9510%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---10.372--------
Intrinsic Value_10Y_min---8.377--------
Intrinsic Value_1Y_max--0.391--------
Intrinsic Value_1Y_min--0.385--------
Intrinsic Value_3Y_max--0.084--------
Intrinsic Value_3Y_min--0.102--------
Intrinsic Value_5Y_max---1.537--------
Intrinsic Value_5Y_min---1.332--------
Market Cap33264654853.120+5%31505666731.24029531673587.757+7%35829277655.603-12%39367899910.064-20%45671854064.554-31%
Net Profit Margin--0.0130.014-8%0.015-13%0.019-30%0.017-22%
Operating Margin---0.010-100%0.030-100%0.027-100%0.017-100%
Operating Ratio--1.9011.890+1%1.892+0%1.885+1%1.498+27%
Pb Ratio1.078+5%1.0211.004+2%1.258-19%1.540-34%2.984-66%
Pe Ratio15.467+5%14.64914.799-1%18.013-19%29.799-51%49.686-71%
Price Per Share8.510+5%8.0607.555+7%9.166-12%10.071-20%11.684-31%
Price To Free Cash Flow Ratio-2.149-6%-2.03527.598-107%14.303-114%15.167-113%7.115-129%
Price To Total Gains Ratio20.411+5%19.3323.667+427%49.469-61%51.174-62%56.175-66%
Quick Ratio--0.5860.558+5%0.677-13%0.643-9%0.661-11%
Return On Assets--0.0060.006-3%0.006-6%0.007-22%0.007-16%
Return On Equity--0.0220.0220%0.023-3%0.027-18%0.023-7%
Total Gains Per Share--0.4170.215+94%0.188+122%0.224+86%0.234+78%
Usd Book Value--4267943616.2814071299213.843+5%3932909334.151+9%3625564837.086+18%2741233160.493+56%
Usd Book Value Change Per Share--0.0490.015+233%0.015+237%0.019+151%0.021+137%
Usd Book Value Per Share--1.0921.042+5%1.006+9%0.928+18%0.701+56%
Usd Dividend Per Share--0.0090.015-42%0.011-24%0.012-25%0.012-25%
Usd Eps--0.0190.019+0%0.019-2%0.021-8%0.015+28%
Usd Free Cash Flow---535267010.161109101374.565-591%82811256.167-746%81391930.260-758%38243108.916-1500%
Usd Free Cash Flow Per Share---0.1370.028-591%0.021-746%0.021-758%0.015-1010%
Usd Free Cash Flow To Equity Per Share---0.1370.008-1798%-0.007-95%0.001-18569%0.001-9510%
Usd Market Cap4600501766.187+5%4357233708.9304084230457.187+7%4955189099.770-12%5444580557.562-20%6316417417.128-31%
Usd Price Per Share1.177+5%1.1151.045+7%1.268-12%1.393-20%1.616-31%
Usd Profit--74360471.64974355102.088+0%75850935.358-2%81039141.541-8%58265172.036+28%
Usd Revenue--5597297962.9025135060074.197+9%5095192771.292+10%4419633557.211+27%3344273442.276+67%
Usd Total Gains Per Share--0.0580.030+94%0.026+122%0.031+86%0.032+78%
 EOD+5 -3MRQTTM+20 -15YOY+13 -225Y+13 -2210Y+17 -18

3.2. Fundamental Score

Let's check the fundamental score of Jointown Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.467
Price to Book Ratio (EOD)Between0-11.078
Net Profit Margin (MRQ)Greater than00.013
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.586
Current Ratio (MRQ)Greater than11.257
Debt to Asset Ratio (MRQ)Less than10.683
Debt to Equity Ratio (MRQ)Less than12.703
Return on Equity (MRQ)Greater than0.150.022
Return on Assets (MRQ)Greater than0.050.006
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Jointown Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.262
Ma 20Greater thanMa 508.291
Ma 50Greater thanMa 1008.117
Ma 100Greater thanMa 2007.711
OpenGreater thanClose8.250
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets97,241,244
Total Liabilities66,381,203
Total Stockholder Equity24,557,701
 As reported
Total Liabilities 66,381,203
Total Stockholder Equity+ 24,557,701
Total Assets = 97,241,244

Assets

Total Assets97,241,244
Total Current Assets79,751,283
Long-term Assets17,489,961
Total Current Assets
Cash And Cash Equivalents 14,390,194
Short-term Investments 88,745
Net Receivables 37,121,596
Inventory 17,680,141
Other Current Assets 251,049
Total Current Assets  (as reported)79,751,283
Total Current Assets  (calculated)69,531,725
+/- 10,219,558
Long-term Assets
Property Plant Equipment 9,041,144
Goodwill 759,681
Intangible Assets 2,082,922
Long-term Assets Other 9,321
Long-term Assets  (as reported)17,489,961
Long-term Assets  (calculated)11,893,069
+/- 5,596,892

Liabilities & Shareholders' Equity

Total Current Liabilities63,454,634
Long-term Liabilities2,926,569
Total Stockholder Equity24,557,701
Total Current Liabilities
Short Long Term Debt 12,129,206
Accounts payable 42,680,971
Other Current Liabilities 115,824
Total Current Liabilities  (as reported)63,454,634
Total Current Liabilities  (calculated)54,926,001
+/- 8,528,633
Long-term Liabilities
Long term Debt 2,010,438
Capital Lease Obligations Min Short Term Debt169,507
Long-term Liabilities Other 116,860
Long-term Liabilities  (as reported)2,926,569
Long-term Liabilities  (calculated)2,296,806
+/- 629,763
Total Stockholder Equity
Retained Earnings 13,233,054
Total Stockholder Equity (as reported)24,557,701
Total Stockholder Equity (calculated)13,233,054
+/- 11,324,646
Other
Capital Stock3,908,892
Common Stock Shares Outstanding 3,908,892
Net Invested Capital 38,697,344
Net Working Capital 16,296,649
Property Plant and Equipment Gross 9,041,144



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-06-302009-12-312008-12-312007-12-31
> Total Assets 
4,423,871
5,718,886
7,167,747
7,255,105
8,119,036
9,364,205
9,949,056
10,577,966
11,838,747
13,382,309
13,555,969
14,310,039
14,803,969
15,858,614
16,675,013
17,603,014
18,596,186
20,589,399
22,214,321
23,188,912
24,125,035
26,829,506
28,205,573
30,873,853
32,584,966
36,769,235
36,883,688
37,599,927
38,728,542
42,886,572
44,696,465
47,571,113
52,048,354
60,146,406
57,588,735
60,878,767
66,674,253
64,962,151
67,017,885
67,691,136
71,147,765
71,819,369
72,854,087
78,716,657
80,823,844
82,231,599
84,301,841
86,807,076
85,935,871
88,674,565
90,668,267
92,993,406
92,272,116
96,415,024
94,168,340
92,938,129
92,789,102
97,241,244
97,241,24492,789,10292,938,12994,168,34096,415,02492,272,11692,993,40690,668,26788,674,56585,935,87186,807,07684,301,84182,231,59980,823,84478,716,65772,854,08771,819,36971,147,76567,691,13667,017,88564,962,15166,674,25360,878,76757,588,73560,146,40652,048,35447,571,11344,696,46542,886,57238,728,54237,599,92736,883,68836,769,23532,584,96630,873,85328,205,57326,829,50624,125,03523,188,91222,214,32120,589,39918,596,18617,603,01416,675,01315,858,61414,803,96914,310,03913,555,96913,382,30911,838,74710,577,9669,949,0569,364,2058,119,0367,255,1057,167,7475,718,8864,423,871
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,587,083
51,516,684
57,056,654
55,308,740
56,356,269
56,813,193
58,902,701
59,294,021
60,229,093
64,916,664
66,150,085
66,539,043
67,135,551
69,526,767
71,169,618
73,551,167
75,263,193
77,259,085
75,657,725
79,567,353
77,172,338
75,808,290
75,625,307
79,751,283
79,751,28375,625,30775,808,29077,172,33879,567,35375,657,72577,259,08575,263,19373,551,16771,169,61869,526,76767,135,55166,539,04366,150,08564,916,66460,229,09359,294,02158,902,70156,813,19356,356,26955,308,74057,056,65451,516,68448,587,0830000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,982,710
6,622,024
12,699,517
9,268,484
9,443,325
9,374,471
12,171,339
11,654,508
9,509,639
10,985,937
14,809,251
11,856,235
12,420,964
11,499,902
14,701,511
13,536,946
14,204,431
14,886,105
17,175,969
15,109,906
15,911,709
14,324,608
16,949,183
14,390,194
14,390,19416,949,18314,324,60815,911,70915,109,90617,175,96914,886,10514,204,43113,536,94614,701,51111,499,90212,420,96411,856,23514,809,25110,985,9379,509,63911,654,50812,171,3399,374,4719,443,3259,268,48412,699,5176,622,0246,982,7100000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
277,286
252,537
224,305
0
302,400
1,512,700
205,700
15,310
3,764
0
5,937
3,597,177
1,208,704
1,369,880
280,848
319,716
99,095
107,443
107,499
90,029
88,745
88,74590,029107,499107,44399,095319,716280,8481,369,8801,208,7043,597,1775,93703,76415,310205,7001,512,700302,4000224,305252,537277,2860000000000000000000000000000000000000
       Net Receivables 
581,697
611,691
773,886
1,479,506
1,470,013
2,949,993
3,233,371
3,997,843
2,505,780
4,949,307
5,223,552
6,197,434
3,859,951
6,184,827
6,860,551
8,095,337
5,193,280
8,654,287
9,328,329
10,782,002
8,140,812
12,173,518
12,788,226
14,128,108
10,877,738
17,309,580
16,878,575
16,999,032
14,533,472
19,412,944
19,904,675
22,099,271
20,037,396
25,604,885
25,129,625
27,934,824
26,497,293
22,805,545
25,803,775
26,140,696
29,070,358
29,303,062
30,314,491
36,783,544
32,507,564
36,200,685
36,125,367
40,562,544
31,305,369
40,090,643
39,678,468
44,007,177
34,762,489
43,885,099
38,661,552
36,255,654
24,719,764
37,121,596
37,121,59624,719,76436,255,65438,661,55243,885,09934,762,48944,007,17739,678,46840,090,64331,305,36940,562,54436,125,36736,200,68532,507,56436,783,54430,314,49129,303,06229,070,35826,140,69625,803,77522,805,54526,497,29327,934,82425,129,62525,604,88520,037,39622,099,27119,904,67519,412,94414,533,47216,999,03216,878,57517,309,58010,877,73814,128,10812,788,22612,173,5188,140,81210,782,0029,328,3298,654,2875,193,2808,095,3376,860,5516,184,8273,859,9516,197,4345,223,5524,949,3072,505,7803,997,8433,233,3712,949,9931,470,0131,479,506773,886611,691581,697
       Other Current Assets 
399,503
570,287
811,721
541,780
695,714
773,404
686,740
708,562
1,295,642
1,075,699
991,236
923,970
1,489,310
1,297,328
1,160,625
1,151,151
1,814,855
1,975,752
1,705,371
1,422,963
1,834,863
1,547,143
1,439,094
1,677,970
2,121,051
2,111,690
1,543,120
2,198,294
2,234,235
1,669,193
1,889,220
2,078,162
2,712,449
2,832,816
2,943,670
3,866,232
3,952,716
413,829
500,069
489,949
3,330,439
3,326,848
4,692,575
3,284,998
3,927,488
3,046,879
4,654,943
3,705,020
5,736,667
3,664,800
5,064,554
3,675,502
6,186,469
4,026,360
5,561,080
216,443
270,871
251,049
251,049270,871216,4435,561,0804,026,3606,186,4693,675,5025,064,5543,664,8005,736,6673,705,0204,654,9433,046,8793,927,4883,284,9984,692,5753,326,8483,330,439489,949500,069413,8293,952,7163,866,2322,943,6702,832,8162,712,4492,078,1621,889,2201,669,1932,234,2352,198,2941,543,1202,111,6902,121,0511,677,9701,439,0941,547,1431,834,8631,422,9631,705,3711,975,7521,814,8551,151,1511,160,6251,297,3281,489,310923,970991,2361,075,6991,295,642708,562686,740773,404695,714541,780811,721570,287399,503
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,653,411
10,661,616
10,877,943
12,245,064
12,525,348
12,624,994
13,799,993
14,673,759
15,692,556
17,166,290
17,280,309
14,766,253
15,123,398
15,405,074
15,734,321
16,614,390
16,847,671
16,996,001
17,129,839
17,163,796
17,489,961
17,489,96117,163,79617,129,83916,996,00116,847,67116,614,39015,734,32115,405,07415,123,39814,766,25317,280,30917,166,29015,692,55614,673,75913,799,99312,624,99412,525,34812,245,06410,877,94310,661,6169,653,4110000000000000000000000000000000000000
       Property Plant Equipment 
547,706
754,776
958,531
1,374,145
1,542,170
1,251,841
1,696,111
1,418,633
1,915,604
1,597,926
2,193,804
1,794,584
2,460,790
1,960,739
2,661,978
2,135,871
2,956,849
2,432,840
2,588,576
2,819,987
2,976,237
3,109,844
3,131,906
3,319,915
3,543,266
3,690,750
3,882,247
4,155,114
4,403,076
4,557,919
4,788,596
5,067,121
5,291,413
5,423,213
5,568,992
5,773,606
6,028,213
6,125,332
7,196,619
7,395,241
6,505,264
6,580,366
6,683,435
7,011,084
7,413,162
7,926,729
8,181,106
8,405,099
8,521,338
8,658,909
8,748,900
8,543,466
8,647,817
8,713,099
8,734,536
8,824,498
8,963,430
9,041,144
9,041,1448,963,4308,824,4988,734,5368,713,0998,647,8178,543,4668,748,9008,658,9098,521,3388,405,0998,181,1067,926,7297,413,1627,011,0846,683,4356,580,3666,505,2647,395,2417,196,6196,125,3326,028,2135,773,6065,568,9925,423,2135,291,4135,067,1214,788,5964,557,9194,403,0764,155,1143,882,2473,690,7503,543,2663,319,9153,131,9063,109,8442,976,2372,819,9872,588,5762,432,8402,956,8492,135,8712,661,9781,960,7392,460,7901,794,5842,193,8041,597,9261,915,6041,418,6331,696,1111,251,8411,542,1701,374,145958,531754,776547,706
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,370
78,275
74,345
74,345
74,345
80,785
81,464
82,333
83,745
84,731
84,848
87,362
89,118
129,068
135,961
145,248
148,155
147,993
149,798
126,187
127,546
122,392
127,226
342,516
341,241
341,241
535,546
554,325
554,325
567,833
575,181
581,433
578,807
574,858
579,400
813,381
800,970
783,026
783,026
759,681
759,681
759,681759,681783,026783,026800,970813,381579,400574,858578,807581,433575,181567,833554,325554,325535,546341,241341,241342,516127,226122,392127,546126,187149,798147,993148,155145,248135,961129,06889,11887,36284,84884,73183,74582,33381,46480,78574,34574,34574,34578,27558,37000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,722,473
1,786,417
1,807,080
1,675,387
1,649,543
1,597,077
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,597,0771,649,5431,675,3871,807,0801,786,4171,722,4730000000000000000000000000000000000
       Intangible Assets 
166,832
252,188
333,266
5,223
5,084
367,355
7,766
404,982
6,908
515,027
8,633
595,121
8,458
690,607
8,152
642,497
7,576
695,185
788,899
806,433
813,775
831,761
831,062
923,135
966,349
974,107
985,264
1,033,327
1,115,511
1,126,329
1,207,425
1,241,630
1,303,003
1,294,509
1,190,615
1,287,108
1,280,301
1,316,558
155,973
1,353,395
2,232,284
2,268,985
2,250,281
2,279,824
2,271,064
2,270,217
2,294,599
2,262,765
2,272,207
2,267,393
2,269,656
2,295,668
2,002,503
2,014,661
2,017,852
2,028,804
2,048,430
2,082,922
2,082,9222,048,4302,028,8042,017,8522,014,6612,002,5032,295,6682,269,6562,267,3932,272,2072,262,7652,294,5992,270,2172,271,0642,279,8242,250,2812,268,9852,232,2841,353,395155,9731,316,5581,280,3011,287,1081,190,6151,294,5091,303,0031,241,6301,207,4251,126,3291,115,5111,033,327985,264974,107966,349923,135831,062831,761813,775806,433788,899695,1857,576642,4978,152690,6078,458595,1218,633515,0276,908404,9827,766367,3555,0845,223333,266252,188166,832
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66,805
21,870
23,654
135,658
134,886
131,669
7,151,487
178,225
190,917
233,167
244,583
37,199
45,072
13,713
18,380
14,877
4,410
13,599
16,788
8,014
9,321
9,3218,01416,78813,5994,41014,87718,38013,71345,07237,199244,583233,167190,917178,2257,151,487131,669134,886135,65823,65421,87066,8050000000000000000000000000000000000000
> Total Liabilities 
3,143,161
4,241,675
5,495,010
5,443,435
4,120,243
5,269,356
5,966,728
6,544,765
7,535,167
8,967,837
8,997,868
9,673,872
9,968,075
10,926,221
11,636,693
12,474,093
13,256,910
13,084,647
14,716,340
15,281,970
16,037,856
18,606,104
19,698,041
21,191,095
22,739,324
25,507,206
25,609,687
26,041,099
26,718,175
29,431,729
30,453,799
32,250,194
32,510,793
40,219,561
37,253,198
41,256,051
46,292,251
45,109,509
46,435,355
47,269,696
49,180,058
50,230,262
50,097,850
53,806,581
55,206,880
55,885,410
57,296,848
59,831,478
58,863,193
61,116,476
62,989,321
64,808,748
63,586,680
67,213,974
65,056,478
64,634,341
63,312,104
66,381,203
66,381,20363,312,10464,634,34165,056,47867,213,97463,586,68064,808,74862,989,32161,116,47658,863,19359,831,47857,296,84855,885,41055,206,88053,806,58150,097,85050,230,26249,180,05847,269,69646,435,35545,109,50946,292,25141,256,05137,253,19840,219,56132,510,79332,250,19430,453,79929,431,72926,718,17526,041,09925,609,68725,507,20622,739,32421,191,09519,698,04118,606,10416,037,85615,281,97014,716,34013,084,64713,256,91012,474,09311,636,69310,926,2219,968,0759,673,8728,997,8688,967,8377,535,1676,544,7655,966,7285,269,3564,120,2435,443,4355,495,0104,241,6753,143,161
   > Total Current Liabilities 
3,060,932
3,973,366
4,995,691
4,877,594
3,665,671
4,642,749
5,510,388
6,121,717
7,150,182
8,791,193
8,846,986
9,510,644
8,279,727
9,286,011
9,973,923
10,002,207
11,573,491
11,405,624
13,054,896
13,612,103
14,365,474
16,922,778
18,010,054
19,476,250
21,009,960
22,537,748
22,633,434
23,050,490
25,259,293
27,968,998
28,870,842
30,611,733
30,701,934
38,265,642
35,288,551
39,271,204
44,266,326
43,016,351
44,338,705
44,188,041
45,947,817
46,869,235
46,728,453
50,235,331
51,332,289
53,239,141
54,060,539
56,159,985
55,394,342
57,241,283
59,075,093
60,813,690
59,684,306
62,980,209
61,122,236
60,898,970
60,065,863
63,454,634
63,454,63460,065,86360,898,97061,122,23662,980,20959,684,30660,813,69059,075,09357,241,28355,394,34256,159,98554,060,53953,239,14151,332,28950,235,33146,728,45346,869,23545,947,81744,188,04144,338,70543,016,35144,266,32639,271,20435,288,55138,265,64230,701,93430,611,73328,870,84227,968,99825,259,29323,050,49022,633,43422,537,74821,009,96019,476,25018,010,05416,922,77814,365,47413,612,10313,054,89611,405,62411,573,49110,002,2079,973,9239,286,0118,279,7279,510,6448,846,9868,791,1937,150,1826,121,7175,510,3884,642,7493,665,6714,877,5944,995,6913,973,3663,060,932
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,833,792
12,472,060
12,595,274
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000012,595,27412,472,06011,833,7920000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,833,792
12,472,060
12,595,274
11,707,156
14,575,353
13,878,381
13,287,902
14,325,101
14,708,974
14,701,932
14,314,945
12,554,545
13,043,796
12,669,380
13,235,393
11,492,879
12,576,839
12,020,078
12,030,290
10,121,827
12,129,206
12,129,20610,121,82712,030,29012,020,07812,576,83911,492,87913,235,39312,669,38013,043,79612,554,54514,314,94514,701,93214,708,97414,325,10113,287,90213,878,38114,575,35311,707,15612,595,27412,472,06011,833,7920000000000000000000000000000000000000
       Accounts payable 
2,077,096
3,098,331
3,122,272
2,765,361
2,472,174
2,704,172
2,920,737
3,459,770
3,679,788
4,289,247
4,418,445
4,829,044
4,274,979
5,095,732
5,193,833
5,420,536
5,928,590
6,678,918
7,222,389
7,913,969
8,637,434
9,627,639
9,153,338
10,472,344
12,032,644
14,378,347
13,488,972
14,580,423
16,213,512
17,198,255
15,910,067
16,336,254
19,166,231
22,384,313
19,020,371
21,740,344
25,442,717
23,263,803
24,731,460
24,799,053
28,019,489
25,822,631
25,313,426
29,887,209
31,098,545
31,346,372
31,658,829
34,474,453
34,158,123
37,271,004
39,644,431
40,760,425
39,295,000
41,818,529
39,712,624
40,488,268
40,101,242
42,680,971
42,680,97140,101,24240,488,26839,712,62441,818,52939,295,00040,760,42539,644,43137,271,00434,158,12334,474,45331,658,82931,346,37231,098,54529,887,20925,313,42625,822,63128,019,48924,799,05324,731,46023,263,80325,442,71721,740,34419,020,37122,384,31319,166,23116,336,25415,910,06717,198,25516,213,51214,580,42313,488,97214,378,34712,032,64410,472,3449,153,3389,627,6398,637,4347,913,9697,222,3896,678,9185,928,5905,420,5365,193,8335,095,7324,274,9794,829,0444,418,4454,289,2473,679,7883,459,7702,920,7372,704,1722,472,1742,765,3613,122,2723,098,3312,077,096
       Other Current Liabilities 
285,106
222,435
252,419
228,533
291,692
460,728
288,055
312,498
311,260
353,316
353,698
374,188
437,841
339,418
416,044
378,882
544,815
438,079
730,541
714,098
743,573
607,827
788,267
843,947
1,172,372
1,318,387
1,789,561
1,578,943
1,600,763
1,800,617
2,891,281
3,064,933
3,480,244
2,947,417
3,543,961
4,325,397
4,519,932
3,584,167
3,096,510
2,635,379
4,820,852
4,183,884
5,112,534
5,201,243
5,398,309
7,010,532
5,657,273
5,368,417
5,695,446
6,708,847
6,090,294
6,039,210
7,821,073
7,114,668
7,402,380
178,339
192,264
115,824
115,824192,264178,3397,402,3807,114,6687,821,0736,039,2106,090,2946,708,8475,695,4465,368,4175,657,2737,010,5325,398,3095,201,2435,112,5344,183,8844,820,8522,635,3793,096,5103,584,1674,519,9324,325,3973,543,9612,947,4173,480,2443,064,9332,891,2811,800,6171,600,7631,578,9431,789,5611,318,3871,172,372843,947788,267607,827743,573714,098730,541438,079544,815378,882416,044339,418437,841374,188353,698353,316311,260312,498288,055460,728291,692228,533252,419222,435285,106
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,093,159
2,096,650
3,081,655
3,232,241
3,361,027
3,369,397
3,571,250
3,874,591
2,646,269
3,236,309
3,671,493
3,468,851
3,875,194
3,914,228
3,995,058
3,902,374
4,233,765
3,934,242
3,735,372
3,246,242
2,926,569
2,926,5693,246,2423,735,3723,934,2424,233,7653,902,3743,995,0583,914,2283,875,1943,468,8513,671,4933,236,3092,646,2693,874,5913,571,2503,369,3973,361,0273,232,2413,081,6552,096,6502,093,1590000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-11,833,792
-12,472,060
-12,595,274
0
0
0
0
0
307,058
294,216
262,794
180,291
211,919
187,872
202,735
195,640
209,985
190,447
179,982
170,986
169,507
169,507170,986179,982190,447209,985195,640202,735187,872211,919180,291262,794294,216307,05800000-12,595,274-12,472,060-11,833,7920000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,912,330
1,917,073
202,256
198,263
189,317
189,220
186,220
92,720
89,720
89,720
86,720
76,720
68,540
61,540
119,180
74,677
74,308
74,145
131,172
116,246
116,860
116,860116,246131,17274,14574,30874,677119,18061,54068,54076,72086,72089,72089,72092,720186,220189,220189,317198,263202,2561,917,0731,912,3300000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
95,165
79,319
100,854
102,522
92,088
94,530
128,381
134,852
105,923
111,065
122,649
144,064
161,822
169,236
196,383
226,009
256,540
282,239
261,012
284,844
288,174
0
0
0
000288,174284,844261,012282,239256,540226,009196,383169,236161,822144,064122,649111,065105,923134,852128,38194,53092,088102,522100,85479,31995,1650000000000000000000000000000000000
> Total Stockholder Equity
1,255,417
1,441,268
1,631,239
1,746,506
3,877,840
3,949,728
3,861,457
3,895,863
4,110,629
4,234,098
4,307,379
4,357,137
4,586,617
4,687,293
4,776,401
4,860,810
5,099,525
7,241,009
7,184,419
7,558,140
7,800,547
7,937,655
8,154,320
9,281,539
9,355,091
10,725,630
10,692,247
10,877,334
11,278,035
12,410,692
13,040,430
14,236,320
18,300,436
18,492,183
18,769,189
17,879,173
18,467,104
17,721,002
18,187,934
17,854,135
18,754,210
18,280,842
19,126,599
21,006,480
21,826,656
22,608,489
23,117,845
23,358,822
23,408,608
23,836,340
23,799,864
24,243,419
24,639,799
25,197,496
25,063,390
23,673,404
23,983,172
24,557,701
24,557,70123,983,17223,673,40425,063,39025,197,49624,639,79924,243,41923,799,86423,836,34023,408,60823,358,82223,117,84522,608,48921,826,65621,006,48019,126,59918,280,84218,754,21017,854,13518,187,93417,721,00218,467,10417,879,17318,769,18918,492,18318,300,43614,236,32013,040,43012,410,69211,278,03510,877,33410,692,24710,725,6309,355,0919,281,5398,154,3207,937,6557,800,5477,558,1407,184,4197,241,0095,099,5254,860,8104,776,4014,687,2934,586,6174,357,1374,307,3794,234,0984,110,6293,895,8633,861,4573,949,7283,877,8401,746,5061,631,2391,441,2681,255,417
   Common Stock
783,200
1,170,516
1,270,516
1,270,516
1,420,516
1,420,516
1,420,516
1,420,516
1,420,516
1,420,516
1,420,516
1,420,516
1,420,516
1,420,516
1,420,516
1,420,516
1,420,516
1,609,617
1,609,617
1,643,075
1,643,075
1,643,075
1,647,009
1,647,009
1,647,009
1,647,009
1,647,009
1,647,025
1,647,026
1,647,027
1,695,658
1,695,659
1,878,878
1,878,878
1,877,664
1,877,664
1,877,664
1,877,664
1,877,664
1,877,664
1,877,664
1,877,664
1,877,665
1,873,811
1,873,817
1,873,817
1,873,817
1,873,801
1,873,826
1,873,869
1,873,869
1,873,869
1,873,869
1,873,869
2,792,065
0
0
0
0002,792,0651,873,8691,873,8691,873,8691,873,8691,873,8691,873,8261,873,8011,873,8171,873,8171,873,8171,873,8111,877,6651,877,6641,877,6641,877,6641,877,6641,877,6641,877,6641,877,6641,877,6641,878,8781,878,8781,695,6591,695,6581,647,0271,647,0261,647,0251,647,0091,647,0091,647,0091,647,0091,647,0091,643,0751,643,0751,643,0751,609,6171,609,6171,420,5161,420,5161,420,5161,420,5161,420,5161,420,5161,420,5161,420,5161,420,5161,420,5161,420,5161,420,5161,420,5161,270,5161,270,5161,170,516783,200
   Retained Earnings 
452,666
234,876
311,109
426,375
636,161
708,049
620,116
654,523
836,187
920,585
984,621
1,025,451
1,220,005
1,317,801
1,397,693
1,461,019
1,664,505
1,930,839
1,865,971
1,952,741
2,217,354
2,335,877
2,467,912
2,589,559
2,911,889
3,053,384
3,007,868
3,098,155
3,517,520
3,653,319
4,260,507
4,365,439
4,856,030
4,969,004
5,096,506
5,220,129
5,789,342
5,571,191
5,799,307
6,020,689
7,180,567
7,699,035
8,402,446
9,219,261
10,154,642
10,914,658
11,405,993
11,518,270
11,546,435
11,998,761
12,160,813
12,600,156
12,950,376
13,511,549
13,250,422
12,623,878
12,695,379
13,233,054
13,233,05412,695,37912,623,87813,250,42213,511,54912,950,37612,600,15612,160,81311,998,76111,546,43511,518,27011,405,99310,914,65810,154,6429,219,2618,402,4467,699,0357,180,5676,020,6895,799,3075,571,1915,789,3425,220,1295,096,5064,969,0044,856,0304,365,4394,260,5073,653,3193,517,5203,098,1553,007,8683,053,3842,911,8892,589,5592,467,9122,335,8772,217,3541,952,7411,865,9711,930,8391,664,5051,461,0191,397,6931,317,8011,220,0051,025,451984,621920,585836,187654,523620,116708,049636,161426,375311,109234,876452,666
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000-339,973-339,973-497,044-497,044-497,044-628,282-142,988-142,988-142,988-250,167-253,742-253,742000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,169,143
3,142,065
3,143,992
2,130,007
2,129,777
2,130,082
2,369,704
1,377,892
1,359,211
457,169
578,667
2,560,006
574,437
559,734
564,732
344,683
363,976
378,567
2,385,092
2,380,383
456,476
0
0
0
000456,4762,380,3832,385,092378,567363,976344,683564,732559,734574,4372,560,006578,667457,1691,359,2111,377,8922,369,7042,130,0822,129,7772,130,0073,143,9923,142,0654,169,1430000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue150,139,847
Cost of Revenue-138,028,963
Gross Profit12,110,88412,110,884
 
Operating Income (+$)
Gross Profit12,110,884
Operating Expense-145,602,712
Operating Income4,537,134-133,491,829
 
Operating Expense (+$)
Research Development196,605
Selling General Administrative5,736,786
Selling And Marketing Expenses0
Operating Expense145,602,7125,933,392
 
Net Interest Income (+$)
Interest Income222,761
Interest Expense-1,317,638
Other Finance Cost-79,417
Net Interest Income-1,174,294
 
Pretax Income (+$)
Operating Income4,537,134
Net Interest Income-1,174,294
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,990,8634,537,134
EBIT - interestExpense = -1,317,638
2,174,043
3,491,681
Interest Expense1,317,638
Earnings Before Interest and Taxes (EBIT)04,308,501
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax2,990,863
Tax Provision-701,202
Net Income From Continuing Ops2,289,6612,289,661
Net Income2,174,043
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,174,294
 

Technical Analysis of Jointown Pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jointown Pharmaceutical Group Co Ltd. The general trend of Jointown Pharmaceutical Group Co Ltd is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jointown Pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jointown Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 8.62 < 8.62 < 8.95.

The bearish price targets are: 7.86 > 7.86 > 7.8071.

Tweet this
Jointown Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jointown Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jointown Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jointown Pharmaceutical Group Co Ltd. The current macd is 0.06009389.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jointown Pharmaceutical Group Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Jointown Pharmaceutical Group Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Jointown Pharmaceutical Group Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jointown Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJointown Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jointown Pharmaceutical Group Co Ltd. The current adx is 13.51.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Jointown Pharmaceutical Group Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Jointown Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jointown Pharmaceutical Group Co Ltd. The current sar is 7.86.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jointown Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jointown Pharmaceutical Group Co Ltd. The current rsi is 59.26. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Jointown Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartJointown Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jointown Pharmaceutical Group Co Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jointown Pharmaceutical Group Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jointown Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartJointown Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jointown Pharmaceutical Group Co Ltd. The current cci is 90.67.

Jointown Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartJointown Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jointown Pharmaceutical Group Co Ltd. The current cmo is 23.52.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Jointown Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJointown Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jointown Pharmaceutical Group Co Ltd. The current willr is -12.16216216.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Jointown Pharmaceutical Group Co Ltd Daily Williams %R ChartJointown Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jointown Pharmaceutical Group Co Ltd.

Jointown Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jointown Pharmaceutical Group Co Ltd. The current atr is 0.24991203.

Jointown Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartJointown Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jointown Pharmaceutical Group Co Ltd. The current obv is 586,638,223.

Jointown Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartJointown Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jointown Pharmaceutical Group Co Ltd. The current mfi is 42.45.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Jointown Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartJointown Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jointown Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Jointown Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jointown Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.262
Ma 20Greater thanMa 508.291
Ma 50Greater thanMa 1008.117
Ma 100Greater thanMa 2007.711
OpenGreater thanClose8.250
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jointown Pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jointown Pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jointown Pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jointown Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Jointown Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jointown Pharmaceutical Group Co Ltd.

Receive notifications about Jointown Pharmaceutical Group Co Ltd in your mailbox!